Clinical Trial Detail

NCT ID NCT02530502
Title Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Northwestern University
Indications

glioblastoma multiforme

Therapies

Temozolomide

Pembrolizumab

Age Groups: adult

No variant requirements are available.